GSK to seek India trials of cervical cancer vaccine
GlaxoSmithKline Biologicals will soon approach the Indian government for permission to conduct efficacy trials of a vaccine for cervical cancer, a disease that kills around 75000 Indians each year.
GlaxoSmithKline Biologicals will soon approach the Indian government for permission to conduct efficacy trials of a vaccine for cervical cancer, a disease that kills around 75000 Indians each year.